Michael Gordon
HonorHealth Research Institute
4 papers found
Refreshing results…
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
Download from aacrjournals.orgMissing publications? Search for publications with a matching author name.